Literature DB >> 29221516

Transculturalizing Diabetes Prevention in Latin America.

Ramfis Nieto-Martínez1, Juan P González-Rivas2, Pablo Aschner3, Noël C Barengo4, Jeffrey I Mechanick5.   

Abstract

BACKGROUND: Type 2 diabetes (T2D) imposes a heavy burden in developing countries, requiring effective primary prevention policies. Randomized clinical trials have identified successful strategies in T2D prevention. However, translating these results to real-life scenarios and adapting to ethnocultural differences is a major challenge. Transculturalization allows incorporating cultural factors to diabetes prevention strategies to optimize implementation of clinical trials results. The purpose of this paper is to review the transcultural adaptations developed for T2D prevention in Latin America (LA).
METHODS: A comprehensive literature review spanning 1960-2016 was performed, using "Diabetes," "Latin America," "Prevention," "Screening," and "Tools" as key words.
RESULTS: Two major tasks are underway in LA: adaptation of screening tools for high-risk individuals, and implementation of diabetes prevention programs. The Finnish Diabetes Risk Score (FINDRISC) is the most widely used screening tool to detect new cases of T2D and people with prediabetes, and it has been adapted (LA-FINDRISC) to include the waist circumference cutoff values appropriate for LA population (≥94 cm for men and ≥90 cm for women). The validation of the LA-FINDRISC performance depends on the local characteristics. A LA-FINDRISC score >10 may be the best cutoff to identify individuals with impaired glucose regulation in population-based studies, but a higher score (>12-14) might be more appropriate in a clinical setting. A shorter version of the FINDRISC using only the 4 variables with highest impact has been developed and validated in Colombia (ColDRISC). The translation of the Diabetes Prevention Program study in a Latino population in Venezuela found a significant improvement in cardiometabolic risk factors. An adaptation of the Diabetes Prevention Study in the DEMOJUAN study in Barranquilla, Colombia, reduced 2-hour postload glucose.
CONCLUSION: Successful transculturalization strategies have been implemented in screening tools and prevention programs in LA.
Copyright © 2017 Icahn School of Medicine at Mount Sinai. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  FINDRISC; Latin America; prevention; type 2 diabetes; validation

Mesh:

Year:  2017        PMID: 29221516     DOI: 10.1016/j.aogh.2017.07.001

Source DB:  PubMed          Journal:  Ann Glob Health        ISSN: 2214-9996            Impact factor:   2.462


  5 in total

1.  FINDRISC Modified for Latin America as a Screening Tool for Persons with Impaired Glucose Metabolism in Ciudad Bolívar, Venezuela.

Authors:  María Carolina Muñoz-González; Marcos M Lima-Martínez; Aura Nava; Gisuardo Trerotola; Mariela Paoli; Julio O Cabrera-Rego; Briggytte Gonzalez; Amilcairy Arciniegas; Javier Paez
Journal:  Med Princ Pract       Date:  2019-03-11       Impact factor: 1.927

2.  Diagnosis of erectile dysfunction can be used to improve screening for Type 2 diabetes mellitus.

Authors:  R M Carrillo-Larco; A C Luza-Dueñas; M Urdániga-Hung; A Bernabé-Ortiz
Journal:  Diabet Med       Date:  2018-08-02       Impact factor: 4.359

3.  Early detection of type 2 diabetes in socioeconomically disadvantaged areas in Stockholm - comparing reach of community and facility-based screening.

Authors:  Linda Timm; Katri Harcke; Ida Karlsson; Kristi Sidney Annerstedt; Helle Mölsted Alvesson; Nouha Saleh Stattin; Birger C Forsberg; Claes-Göran Östenson; Meena Daivadanam
Journal:  Glob Health Action       Date:  2020-12-31       Impact factor: 2.640

4.  Diagnostic accuracy of the Finnish Diabetes Risk Score (FINDRISC) for undiagnosed T2DM in Peruvian population.

Authors:  Antonio Bernabe-Ortiz; Pablo Perel; Juan Jaime Miranda; Liam Smeeth
Journal:  Prim Care Diabetes       Date:  2018-08-18       Impact factor: 2.459

5.  Effectiveness of the Diabetes Prevention Program for Obesity Treatment in Real World Clinical Practice in a Middle-Income Country in Latin America.

Authors:  Brianda Armenta-Guirado; Teresita Martínez-Contreras; Maria C Candia-Plata; Julián Esparza-Romero; Raúl Martínez-Mir; Michelle M Haby; Mauro E Valencia; Rolando G Díaz-Zavala
Journal:  Nutrients       Date:  2019-10-01       Impact factor: 5.717

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.